Cyclo Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
16.08.2022 - Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, ...
United States South Africa Cynthiaa Lemere Caroline Hastings Company Transport World Orphan Drug Congress United States
Source: wallstreet-online.de